New application of gastrodin in suppressing addiction of opioid drugs
An opioid drug, gastrodin technology, a new application in the treatment of opioid drug addiction, gastrodin preparations and pharmaceutical compositions containing it, gastrodin field, able to solve the research on gastrodin addiction that has not been seen Reporting and other issues
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0015] Embodiment 1: Oxycodone addiction model experiment
[0016] 1.1 Experimental materials
[0017] 1.1.1 Animals: 10 healthy young DSS (Dahl / Salt sensitive rat) rats aged 7-8 weeks, body weight 180-200 g, provided by Changchun Yisi Experimental Animal Technology, animal license number SCXK (Ji) -2019-0003. Rats were fed with standard feed, free to eat and drink, lighted for 12 hours at 8:00 am every day, kept at room temperature (25 ± 2°C), fasted and water-free during the experiment, and noise interference was avoided.
[0018] 1.1.2 Experimental reagent: oxycodone hydrochloride (Beijing Huasu Pharmaceutical Co., Ltd.).
[0019] 1.1.3 Experimental equipment: conditioned place preference device (Med Associates, USA); self-administration experiment device (modified by conditioned place preference device, including two external drinking water stoppers (one of which is connected to the infusion pump drug delivery device), A series of devices such as lick test water bottle ...
Embodiment 2
[0033] Embodiment 2: Model experiment of rat lateral ventricle microdialysis administration
[0034] 2.1 Experimental materials
[0035] 2.1.1 Animals: Female DSS (Dahl / Salt sensitive rat) rats are the same as "1.1.1". Free to eat and drink, the room temperature was kept at (25 ± 2 ℃), and the light was 12 hours at 8:00 am every day. During the experiment, food and water were fasted and noise interference was avoided.
[0036] 2.1.2 Experimental reagents: Oxycodone hydrochloride (Beijing Huasu Pharmaceutical Co., Ltd.), isoflurane (Wuxi Biome Biotechnology Co., Ltd.), carprofen (Qingdao Kangdien Pharmaceutical Co., Ltd.), en Nofloxacin (Tianjin Ruipu Biological Pharmaceutical Co., Ltd.).
[0037] 2.1.3 Experimental equipment: rat brain stereotaxic instrument (Rivet Life Science Co., Ltd.); dental benchtop electric drill (Shanghai Huanxi Medical Instrument Co., Ltd.); conditioned place preference device (Med Associates, USA); self-administration Experimental device (modified...
Embodiment 3
[0047] Example 3: Intervention experiment of gastrodin on oxycodone-addicted rats
[0048] 3.1 Experimental materials
[0049] 3.1.1 Animals and grouping: 18 healthy young 8-week-old female DSS (Dahl / Salt sensitive rats) rats, weighing 180-200 g, provided by Changchun Yisi Experimental Animal Technology, animal license number SCXK (Ji) -2019-0003. After the oxycodone addiction model, the lateral ventricle microdialysis operation was randomly divided into three groups, 6 rats in each group, which were the control group, the gastrodin low-dose group (50 μg) and the high-dose group (200 μg) . They were all fed with standard feed, free to eat and drink, lighted for 12 hours at 8:00 am every day, kept at room temperature (25 ± 2 ℃), fasted before the experiment and avoided noise interference.
[0050] 3.1.2 Experimental reagents: gastrodin (Shanghai Yuanye Biotechnology Co., Ltd., batch number: B21243, purity ≥ 98%); NaCl, KCl, CaCl 2 , MgCl 2 、Na 2 HPO 4 , NaH 2 PO 4 (Bei...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com